Prolactin: a new therapeutic target in peripartum cardiomyopathy

Heart
Hatice YamacDenise Hilfiker-Kleiner

Abstract

Peripartum/postpartum cardiomyopathy (PPCM) is a potentially life-threatening disease of uncertain aetiology in previously healthy women. Clinical and experimental data suggested inflammation, autoimmune processes, apoptosis and endothelial dysfunction as typical pathophysiological features of PPCM. Recent data discovered that unbalanced peri/postpartum oxidative stress linked to proteolytic cleavage of the nursing hormone prolactin into a potent anti-angiogenic, pro-apoptotic and pro-inflammatory 16-kDa subform as a potential pathomechanism for the development of PPCM. Consistent with these idea, blockade of prolactin by bromocriptine, a dopamine D2 receptor agonist, prevented the onset of disease in an experimental model of PPCM and appeared successful in small pilot trials with respect to prevention or treatment of PPCM in patients. Here we highlight the current state of knowledge on diagnosis of PPCM, provide novel insights into the pathophysiology behind the disease and outline potential consequences for the clinical management and treatment options for patients at risk for or with PPCM.

Citations

Apr 16, 2013·Der Anaesthesist·B LöserD A Reuter
Jul 24, 2012·Current Heart Failure Reports·John D Rutherford
Sep 26, 2012·Current Treatment Options in Cardiovascular Medicine·Garrick C Stewart
Nov 5, 2013·Gynécologie, obstétrique & fertilité·E MassouG Benoist
Jan 10, 2013·International Journal of Women's Health·Michael Capriola
May 5, 2012·La Presse médicale·Gérald VanzettoOlivier Chavanon
Dec 14, 2011·Autoimmunity Reviews·Shahar ShellyHedi Orbach
Oct 19, 2011·Proteomics. Clinical Applications·Viktoria StelzhammerSabine Bahn
Mar 18, 2015·Nature Reviews. Endocrinology·Valérie BernardNadine Binart
Mar 19, 2015·The American Journal of Emergency Medicine·Alyson J McGregorKaren Rosene-Montella
Jun 14, 2017·Seminars in Dialysis·Ozkan GungorMahmut Ilker Yılmaz
Oct 17, 2013·Journal of Molecular Endocrinology·Nelson D Horseman, Karen A Gregerson
Nov 10, 2017·Journal of the Intensive Care Society·Michael HoyVenkat Prasad
Dec 11, 2019·Current Treatment Options in Cardiovascular Medicine·Shilpa Sharma, Sunu S Thomas
Oct 12, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Xiao-Bing JiangHai-Jun Wang
Jul 7, 2017·Cardiology and Therapy·Reza Ashrafi, Stephanie L Curtis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.